Braeburn

Pharmaceutical company marketing BRIXADI, a prescription product for opioid use disorder treatment

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

Recent signals

What changed at Braeburn in the last 6 months, newest first. Each line links to its public source.

Get signals like these for the companies you sell to →

About Braeburn

Braeburn is a pharmaceutical company focused on the management of opioid use disorder (OUD). Its product page lists BRIXADI, a prescription product, with full prescribing information and a medication guide. The company states its purpose as transforming how OUD is managed and empowering people on their recovery journey.

Its stated audience is people in recovery from opioid use disorder. The company runs community partnerships and volunteer work with organisations addressing the opioid crisis, and produces a docuseries and thought-leadership articles on recovery. Its leadership team includes a President and CEO, a Chief Medical Officer and a Chief Financial Officer.

Current job openings are in field sales, field medical affairs, marketing and sales operations, several of them remote roles in US regions. The careers page describes a period of growth at the company.

Product: BRIXADI, a prescription product for opioid use disorder, with prescribing information and a medication guide available on the company site.

Jobs at Braeburn

No open positions in Europe right now.

Open roles at Braeburn in the Americas (3)

United States 3. From Braeburn's careers page or applicant tracking system; each role links to the employer.

More biotech & pharma companies

  • BridgeBio Pharma

    Develops drugs for rare genetic conditions, including ATTR amyloidosis, achondroplasia and muscular dystrophy
    United StatesBiotech & pharma18 open jobs
    GrowingRemote-friendly
  • Bristolmyerssquibb

    Discovers, develops and supplies medicines for patients with serious diseases worldwide
    New York, United StatesBiotech & pharma109 open jobs
  • cAMPfield Therapeutics

    Clinical-stage biopharma developing prifemilast, an oral PDE4B inhibitor, for ulcerative colitis and Crohn's disease
    San Diego, United StatesBiotech & pharmaFounded 2026
    Young companyNew on Evolc
  • Capable Labs

    AI-driven therapeutics developer building peptide and RNA drugs, starting with sleep disorder programs
    United StatesBiotech & pharma
    New on Evolc
  • Cellanome

    Live-cell imaging and single-cell transcriptomics platform for biology research labs and biopharma companies
    United StatesBiotech & pharma
    New on Evolc
  • Cogent Biosciences

    Develops precision therapies for patients with genetically defined diseases, including cancers and rare diseases
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Gravity FormsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Privacy & consent

  • OneTrustHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • GreenhouseHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.